Nurözler Ayşe Burcu, Salvarli Sibel, Budak Koray, Onat Mustafa, Duman Sunay
Ankara Hospital Eye Clinic, Ankara, Turkey.
Jpn J Ophthalmol. 2004 Jul-Aug;48(4):368-71. doi: 10.1007/s10384-004-0083-x.
By a retrospective study of patients in the Ankara Hospital Eye Clinic, to determine the anatomical and visual results of therapeutic penetrating keratoplasty (PK) and its role in the management of corneal disease.
Therapeutic PK was performed in 36 patients (37 eyes) who had corneal perforation due to corneal disease (23 eyes) or eyes in which perforation was imminent (14 eyes). Initial indications for grafting were nonperforated descemetocele without inflammation (six eyes, 16.2%); nonperforated bacterial corneal ulcer (five eyes, 13.5%); nonperforated herpetic keratitis with active stromal inflammation (two eyes, 5.4%); acanthamoeba keratitis (one eye, 2.7%); perforation due to herpetic keratitis (13 eyes, 35.2%); perforation due to persistent epithelial defect (8 eyes, 21.6%); or perforation due to bacterial corneal ulcer (two eyes; 5.4%). The results were evaluated for each of the following criteria: anatomical integrity of the eye, cure of the disease, complications, graft clarity, and visual acuity.
Anatomical integrity was achieved in 21 of the 23 eyes (91.3%) perforated from corneal disease. Therapeutic PK cured the disease in all bacterial keratitis cases. The proportion of clear grafts was 60.9% in the 23 eyes perforated from corneal disease, and 57.1% in the 14 eyes in which perforation was imminent. Fifteen eyes (40.5%) obtained a final visual acuity of 20/100 or better; five of these eyes were not yet perforated before the PK.
Therapeutic PK is effective in the management of the eye with active uncontrolled infection or perforation from corneal disease. Approximately half of our patients maintained a clear graft at the last visit. Without therapeutic surgery, these eyes would have been lost.
通过对安卡拉医院眼科门诊患者进行回顾性研究,确定治疗性穿透性角膜移植术(PK)的解剖学和视觉效果及其在角膜疾病治疗中的作用。
对36例(37只眼)因角膜疾病导致角膜穿孔(23只眼)或即将穿孔的眼(14只眼)进行治疗性PK。最初的移植指征为无炎症的非穿孔性后弹力层膨出(6只眼,16.2%);非穿孔性细菌性角膜溃疡(5只眼,13.5%);伴有活动性基质炎症的非穿孔性疱疹性角膜炎(2只眼,5.4%);棘阿米巴角膜炎(1只眼,2.7%);疱疹性角膜炎导致的穿孔(13只眼,35.2%);持续性上皮缺损导致的穿孔(8只眼,21.6%);或细菌性角膜溃疡导致的穿孔(2只眼,5.4%)。根据以下各项标准对结果进行评估:眼的解剖完整性、疾病治愈情况、并发症、植片清晰度和视力。
23只因角膜疾病穿孔的眼中,21只(91.3%)实现了解剖完整性。治疗性PK治愈了所有细菌性角膜炎病例。23只因角膜疾病穿孔的眼中,植片清晰的比例为60.9%,14只即将穿孔的眼中为57.1%。15只眼(40.5%)最终视力达到20/100或更好;其中5只眼在PK前尚未穿孔。
治疗性PK对伴有活动性未控制感染或角膜疾病穿孔的眼有效。在我们的患者中,约一半在最后一次随访时保持植片清晰。若无治疗性手术,这些眼将会失明。